Esposito Pamela
- SEC CIK
- 0001744425
In the past year, 4 open-market sale filings worth $3.05M and no purchases.
Current role at each company
- KYMR Kymera Therapeutics, Inc.Directoras of Jun 25, 2026
- REPL Replimune Group, Inc.Chief Business Officeras of Sep 13, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.05M
- 4 filings
- Net
- −$3.05M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Esposito Pamela as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KYMR Kymera Therapeutics, Inc.
Director7 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 20, 2026 (view filing) | Mar 20 | Same day | Esposito PamelaDirector | SSale | −2.50K | $79.15 | −$197.9K | −100.0%0 after | 3 lots10b5-1 |
| Feb 20, 2026 (view filing) | Feb 20 | Same day | Esposito PamelaDirector | SSale | −2.50K | $87.31 | −$218.3K | −100.0%0 after | 2 lots10b5-1 |
| Jan 20, 2026 (view filing) | Jan 20 | Same day | Esposito PamelaDirector | SSale | −5.50K | $67.91 | −$373.5K | −100.0%0 after | 3 lots10b5-1 |
| Dec 17, 2025 (view filing) | Dec 17 | Same day | Esposito PamelaDirector | SSale | −27.6K | $82.16 | −$2.26M | −100.0%0 after | 4 lots10b5-1 |
| Jun 3, 2025 (view filing) | Jun 3 | Same day | Esposito PamelaDirector | SSale | −5.00K | $49.04 | −$245.2K | −100.0%0 after | 10b5-1 |
| Dec 2, 2024 (view filing) | Dec 2 | Same day | Esposito PamelaDirector | SSale | −2.50K | $49.00 | −$122.5K | −100.0%0 after | 10b5-1 |
| Sep 17, 2024 (view filing) | Sep 17 | Same day | Esposito PamelaDirector | SSale | −13.5K | $48.28 | −$651.8K | −100.0%0 after | 2 lots10b5-1 |
REPL Replimune Group, Inc.
Chief Business Officer11 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 13, 2023 (view filing) | Sep 11-12 | 2 days | Esposito PamelaChief Business Officer | SSale | −5.66K | $20.01 | −$113.2K | −2.1%263.4K after | 2 lots10b5-1 |
| Aug 24, 2023 (view filing) | Aug 22 | 2 days | Esposito PamelaChief Business Officer | SSale | −18.6K | $20.01 | −$372.2K | −6.6%263.4K after | 10b5-1 |
| Aug 15, 2023 (view filing) | Aug 11 | 4 days | Esposito PamelaChief Business Officer | SSale | −1.40K | $20.00 | −$28.0K | −0.5%263.4K after | 10b5-1 |
| Jul 11, 2023 (view filing) | Jul 10 | 1 day | Esposito PamelaChief Business Officer | SSale | −20.0K | $21.58 | −$431.5K | −7.1%263.4K after | 2 lots10b5-1 |
| May 18, 2023 (view filing) | May 16 | 2 days | Esposito PamelaChief Business Officer | SSale | −5.97K | $18.05 | −$107.7K | −2.2%263.4K after | |
| Dec 13, 2022 (view filing) | Dec 9 | 4 days | Esposito PamelaChief Business Officer | SSale | −15.0K | $25.03 | −$375.4K | −6.1%229.4K after | |
| May 18, 2022 (view filing) | May 16 | 2 days | Esposito PamelaChief Business Officer | SSale | −3.51K | $14.59 | −$51.2K | −1.5%229.4K after | |
| Aug 6, 2021 (view filing) | Aug 4-5 | 2 days | Esposito PamelaChief Business Officer | SSale | −30.0K | $35.08 | −$1.05M | −12.5%210.2K after | 2 lots |
| Jul 22, 2021 (view filing) | Jul 20-21 | 2 days | Esposito PamelaChief Business Officer | SSale | −17.4K | $33.14 | −$576.6K | −7.6%210.2K after | 2 lots |
| Jul 19, 2021 (view filing) | Jul 15 | 4 days | Esposito PamelaChief Business Officer | SSale | −4.60K | $33.37 | −$153.5K | −2.1%210.2K after |